Compound ID | 2279
Class: Antimicrobial peptide
Spectrum of activity: | Gram-positive |
Details of activity: | Active against vancomycin resistant Enterococci, methicillin-resistant Staphylococcus aureus, and Staphylococcus aureus; targets bacterial membrane |
Propensity to select resistant mutants: | No |
Description: | Synthetic compound (horizontal helix); not cytotoxic to human cells (human liver & kidney cells LD50 at >80 uM and human lung fibroblasts LD50 >25 uM) at MIC required to inhibit VRE and MRSA (MIC 2-4 uM); no murine nephrotoxicity observed; systemic efficacy observed vs S. aureus infection (87.5% mouse survival rate) |
Year first mentioned: | 2020 |
Development status: | Experimental |
External links: | |
Citation: | https://www.pnas.org/doi/10.1073/pnas.2005540117 |